301087 可孚医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入2,397,7926.63%2,982,9312,853,6952,976,9582,275,633
减:营业总成本2,140,9388.52%2,630,6582,594,3862,646,2911,832,260
    其中:营业成本1,118,4632.30%1,436,0841,618,6611,800,6831,278,216
               财务费用(3,774)-77.05%(22,828)(19,062)(33,291)(6,581)
               资产减值损失(27,752)-12.39%(33,803)(52,180)(46,304)(17,842)
公允价值变动收益13,886457.76%9,400(1,563)4,4026,331
投资收益18,18120.86%12,34247,71556,750(306)
    其中:对联营企业和合营企业的投资收益1,366195.75%(3,498)(130)(21)(306)
营业利润301,8112.39%373,304294,728368,407511,033
利润总额304,1773.13%371,999285,708334,388508,329
减:所得税费用44,6693.83%59,65632,83732,36978,743
净利润259,5083.00%312,344252,871302,020429,586
减:非控股权益(710)-3,432.30%593(1,409)336729
股东净利润260,2173.30%311,751254,280301,683428,857

市场价值指针
每股收益 (元) *1.2803.23%1.5301.2401.4502.600
每股派息 (元) *0.6000.00%1.8001.2001.2001.600
每股净资产 (元) *22.565-0.53%22.94023.41424.08030.920
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容